Risk of Business Contraction Due to Natural Disasters and Infectious Diseases
First written in FY2016. 5 of 10 entries say "Materialised", first in FY2020. Latest entry: FY2023.
Kyokuto Securities moved to the "Worse" side of this theme in 2020, the same year as the typical company in this theme.
The whole theme swung hardest in 2020: 15 of 22 companies on the "Worse" side.
3 other companies' latest entry also says "Mitigated".
- FY2023MitigatedAnnual report
「Since 8 May 2023, COVID-19 has been classified as a Category V infectious disease under the Act on the Prevention of Infectious Diseases and Medical Care for Patients with Infectious Diseases, and no significant subsequent spread has occurred.」
While stating that the risk from infectious diseases remains, it describes a decline in the number of infected people, the reclassification of COVID-19 as a Category V infectious disease, and the absence of any significant spread. - FY2021MaterialisedAnnual report
「The Group has taken various measures in advance in anticipation of large-scale natural disasters such as earthquakes and the resulting infrastructure disruptions, as well as the spread of pathogenic infectious diseases such as COVID-19, including pandemics. However, it is difficult to avoid all risks arising from such disasters and other events. If these risks materialize on a scale exceeding expectations, forcing the Group to scale back its business, or if deficiencies in its business continuity plan make it impossible to maintain operations, the Group may incur not only direct losses arising from those events but also a decline in future revenue, which may affect its operating results and financial position.」
It states that although the spread of COVID-19 continued, the economy was in a recovery phase due to vaccines, monetary easing and other measures. - FY2021-Q3MaterialisedAnnual report
「The domestic and overseas economic environment during the cumulative third quarter deteriorated sharply from April to June as the spread of COVID-19 affected the global economy. Although lockdowns were reinstated in various countries thereafter, the global economy continued to recover on the back of unprecedented monetary and fiscal policies implemented by countries worldwide.」
The spread of COVID-19 and the resulting lockdowns continued to cause a decline in the global economy. At the same time, it states that the global economy continued to recover on the back of monetary and fiscal policies. - FY2021-Q2MaterialisedAnnual report
「The domestic and overseas economic environment during the cumulative second quarter deteriorated sharply from April to June as the spread of COVID-19 affected the global economy. Although COVID-19 infections subsequently began to spread again, the global economy entered a recovery trend as lockdowns were increasingly lifted and governments in various countries implemented fiscal policies on an unprecedented scale.」
The spread and renewed spread of COVID-19 continued, resulting in a substantial decline in the global economy from April to June. It states that the economy subsequently entered a recovery trend as lockdowns were lifted and fiscal policies were implemented. - FY2021-Q1MaterialisedAnnual report
「The domestic and overseas economies during the cumulative first quarter deteriorated rapidly as economic activity was restricted by lockdowns and other measures implemented worldwide to prevent the spread of COVID-19.」
The global spread of COVID-19, including lockdowns and restrictions on economic activity, continued to occur in practice, resulting in a rapid deterioration in the domestic and overseas economies during the cumulative first quarter. - FY2020MaterialisedAnnual report
「The Group has taken various measures in advance in anticipation of large-scale natural disasters such as earthquakes and the resulting infrastructure disruptions, as well as the spread of pathogenic infectious diseases such as COVID-19, including pandemics. However, it is difficult to avoid all risks arising from such disasters and other events. If these risks materialize on a scale exceeding expectations, forcing the Group to scale back its business, or if deficiencies in its business continuity plan make it impossible to maintain operations, the Group may incur not only direct losses arising from those events but also a decline in future revenue, which may affect its operating results and financial position.」
In addition to the conventional general risks from natural disasters and infectious diseases, the global spread of COVID-19 is described as an event that actually occurred and was accompanied by market disruption and lower revenue. - FY2019RestatedAnnual report
「If the Group is forced to scale back its business due to natural disasters, resulting disruptions or the spread of pathogenic infectious diseases, its operating results and financial position may be affected.」
Reiterates the risk of business contraction due to natural disasters, related disruptions and the spread of infectious diseases. - FY2018RestatedAnnual report
「If the Group is forced to scale back its business due to natural disasters, resulting disruptions or the spread of pathogenic infectious diseases, its operating results and financial position may be affected.」
Reiterates the risk of business contraction due to natural disasters, related disruptions and the spread of infectious diseases. - FY2017RestatedAnnual report
「If the Group is forced to scale back its business due to natural disasters, resulting disruptions or the spread of pathogenic infectious diseases, its operating results and financial position may be affected.」
Reiterates the risk of business contraction due to natural disasters, related disruptions and the spread of infectious diseases. - FY2016First statedAnnual report
「If the Group is forced to scale back its business due to natural disasters, resulting disruptions or the spread of pathogenic infectious diseases, its operating results and financial position may be affected.」
Discloses the possibility of business contraction due to natural disasters, related disruptions and the spread of pathogenic infectious diseases.